FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207919029> ?p ?o ?g. }

• W3207919029 endingPage "3661" @default.
• W3207919029 startingPage "3661" @default.
• W3207919029 abstract "Patients with multiple sclerosis (MS) are characterized by, among other symptoms, impaired functional capacity and walking difficulties. Polyunsaturated fatty acids (PUFAs) have been found to improve MS patients' clinical outcomes; however, their effect on other parameters associated with daily living activities need further investigation. The current study aimed to examine the effect of a 24-month supplementation with a cocktail dietary supplement formula, the NeuroaspisTM PLP10, containing specific omega-3 and omega-6 PUFAs and specific antioxidant vitamins on gait and functional capacity parameters of patients with MS. Fifty-one relapsing-remitting MS (RRMS) patients with low disability scores (age: 38.4 ± 7.1 years; 30 female) were randomized 1:1 to receive either a 20 mL daily dose of the dietary formula containing a mixture of omega-3 and omega-6 PUFAs (12,150 mg), vitamin A (0.6 mg), vitamin E (22 mg), and γ-tocopherol (760 mg), the OMEGA group (n = 27; age: 39 ± 8.3 years), or 20 mL placebo containing virgin olive oil, the placebo group (n = 24; age: 37.8 ± 5.3 years). The mean ± SD (standard deviation) Expanded Disability Status Scale (EDSS) score for the placebo group was 2.36 and for the OMEGA group 2.22. All enrolled patients in the study were on Interferon-β treatment. Spatiotemporal gait parameters and gait deviation index (GDI) were assessed using a motion capture system. Functional capacity was examined using various functional tests such as the six-minute walk test (6MWT), two sit-to-stand tests (STS-5 and STS-60), and the Timed Up and Go test (TUG). Isometric handgrip strength was assessed by a dynamometer. Leg strength was assessed using an isokinetic dynamometer. All assessments were performed at baseline and at 12 and 24 months of supplementation. A total of 36 patients completed the study (18 from each group). Six patients from the placebo group and 9 patients from the OMEGA group dropped out from the study or were lost to follow-up. The dietary supplement significantly improved the single support time and the step and stride time (p < 0.05), both spatiotemporal gait parameters. In addition, while GDI of the placebo group decreased by about 10% at 24 months, it increased by about 4% in the OMEGA group (p < 0.05). Moreover, performance in the STS-60 test improved in the OMEGA group (p < 0.05) and there was a tendency for improvement in the 6MWT and TUG tests. Long-term supplementation with high dosages of omega-3 and omega-6 PUFAs (compared to previous published clinical studies using PUFAs) and specific antioxidant vitamins improved some functional capacity and gait parameters in RRMS patients." @default.
• W3207919029 created "2021-10-25" @default.
• W3207919029 creator A5004010381 @default.
• W3207919029 creator A5010072895 @default.
• W3207919029 creator A5021386391 @default.
• W3207919029 creator A5021668832 @default.
• W3207919029 creator A5026622069 @default.
• W3207919029 creator A5034452319 @default.
• W3207919029 creator A5074645101 @default.
• W3207919029 creator A5082209853 @default.
• W3207919029 date "2021-10-19" @default.
• W3207919029 modified "2023-10-01" @default.
• W3207919029 title "The Effects of Specific Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Antioxidant Vitamins on Gait and Functional Capacity Parameters in Patients with Relapsing-Remitting Multiple Sclerosis" @default.
• W3207919029 cites W16535422 @default.
• W3207919029 cites W1973548777 @default.
• W3207919029 cites W1974704788 @default.
• W3207919029 cites W1976953979 @default.
• W3207919029 cites W1983027864 @default.
• W3207919029 cites W1985119666 @default.
• W3207919029 cites W1991407193 @default.
• W3207919029 cites W1995528017 @default.
• W3207919029 cites W2002307032 @default.
• W3207919029 cites W2003742862 @default.
• W3207919029 cites W2013159382 @default.
• W3207919029 cites W2014873712 @default.
• W3207919029 cites W2015984624 @default.
• W3207919029 cites W2019627189 @default.
• W3207919029 cites W2024300012 @default.
• W3207919029 cites W2027285375 @default.
• W3207919029 cites W2033993719 @default.
• W3207919029 cites W2035541251 @default.
• W3207919029 cites W2037980702 @default.
• W3207919029 cites W2043572283 @default.
• W3207919029 cites W2044461625 @default.
• W3207919029 cites W2047274816 @default.
• W3207919029 cites W2051562699 @default.
• W3207919029 cites W2057967890 @default.
• W3207919029 cites W2060969870 @default.
• W3207919029 cites W2061693020 @default.
• W3207919029 cites W2065262862 @default.
• W3207919029 cites W2071015042 @default.
• W3207919029 cites W2072862028 @default.
• W3207919029 cites W2078513771 @default.
• W3207919029 cites W2083913951 @default.
• W3207919029 cites W2084110857 @default.
• W3207919029 cites W2091771874 @default.
• W3207919029 cites W2097303544 @default.
• W3207919029 cites W2098291431 @default.
• W3207919029 cites W2102005177 @default.
• W3207919029 cites W2106451674 @default.
• W3207919029 cites W2108479646 @default.
• W3207919029 cites W2111553898 @default.
• W3207919029 cites W2112156377 @default.
• W3207919029 cites W2112374874 @default.
• W3207919029 cites W2117428376 @default.
• W3207919029 cites W2122545833 @default.
• W3207919029 cites W2125533119 @default.
• W3207919029 cites W2130614813 @default.
• W3207919029 cites W2131620744 @default.
• W3207919029 cites W2152807923 @default.
• W3207919029 cites W2162572469 @default.
• W3207919029 cites W2288073912 @default.
• W3207919029 cites W2526655035 @default.
• W3207919029 cites W2762310135 @default.
• W3207919029 cites W2899113672 @default.
• W3207919029 cites W2906724270 @default.
• W3207919029 cites W2971099683 @default.
• W3207919029 cites W3001233619 @default.
• W3207919029 cites W3088232264 @default.
• W3207919029 cites W4292091612 @default.
• W3207919029 doi "https://doi.org/10.3390/nu13103661" @default.
• W3207919029 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8540949" @default.
• W3207919029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34684661" @default.
• W3207919029 hasPublicationYear "2021" @default.
• W3207919029 type Work @default.
• W3207919029 sameAs 3207919029 @default.
• W3207919029 citedByCount "7" @default.
• W3207919029 countsByYear W32079190292022 @default.
• W3207919029 countsByYear W32079190292023 @default.
• W3207919029 crossrefType "journal-article" @default.
• W3207919029 hasAuthorship W3207919029A5004010381 @default.
• W3207919029 hasAuthorship W3207919029A5010072895 @default.
• W3207919029 hasAuthorship W3207919029A5021386391 @default.
• W3207919029 hasAuthorship W3207919029A5021668832 @default.
• W3207919029 hasAuthorship W3207919029A5026622069 @default.
• W3207919029 hasAuthorship W3207919029A5034452319 @default.
• W3207919029 hasAuthorship W3207919029A5074645101 @default.
• W3207919029 hasAuthorship W3207919029A5082209853 @default.
• W3207919029 hasBestOaLocation W32079190291 @default.
• W3207919029 hasConcept C124490489 @default.
• W3207919029 hasConcept C126322002 @default.
• W3207919029 hasConcept C142724271 @default.
• W3207919029 hasConcept C185592680 @default.
• W3207919029 hasConcept C1862650 @default.
• W3207919029 hasConcept C19038510 @default.
• W3207919029 hasConcept C203014093 @default.
• W3207919029 hasConcept C204787440 @default.
• W3207919029 hasConcept C27081682 @default.

• next